Fifth Third Bancorp Grows Position in Sotera Health Company $SHC

Fifth Third Bancorp raised its stake in shares of Sotera Health Company (NASDAQ:SHC) by 2,453.6% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 54,468 shares of the company’s stock after purchasing an additional 52,335 shares during the quarter. Fifth Third Bancorp’s holdings in Sotera Health were worth $781,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in SHC. CenterBook Partners LP lifted its position in Sotera Health by 94.1% during the 4th quarter. CenterBook Partners LP now owns 151,529 shares of the company’s stock worth $2,673,000 after acquiring an additional 73,473 shares during the period. Capricorn Fund Managers Ltd purchased a new stake in Sotera Health during the 4th quarter valued at about $7,936,000. Retirement Systems of Alabama grew its stake in Sotera Health by 16.9% during the 4th quarter. Retirement Systems of Alabama now owns 248,899 shares of the company’s stock valued at $4,391,000 after purchasing an additional 35,974 shares during the last quarter. Exchange Traded Concepts LLC acquired a new position in shares of Sotera Health in the fourth quarter valued at about $7,739,000. Finally, Geode Capital Management LLC increased its holdings in shares of Sotera Health by 13.8% in the fourth quarter. Geode Capital Management LLC now owns 3,931,834 shares of the company’s stock valued at $69,372,000 after purchasing an additional 476,365 shares during the period. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Analyst Ratings Changes

A number of research firms recently commented on SHC. Piper Sandler reaffirmed an “overweight” rating and set a $22.00 target price (down from $24.00) on shares of Sotera Health in a report on Wednesday, May 6th. UBS Group set a $19.00 price target on shares of Sotera Health in a report on Wednesday, June 24th. Weiss Ratings raised shares of Sotera Health from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, July 9th. Barclays raised their price target on shares of Sotera Health from $18.00 to $19.00 and gave the stock an “overweight” rating in a research report on Wednesday, June 24th. Finally, The Goldman Sachs Group began coverage on shares of Sotera Health in a report on Friday, June 5th. They issued a “buy” rating and a $20.00 price objective on the stock. Eight equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, Sotera Health presently has a consensus rating of “Moderate Buy” and an average price target of $20.25.

Insiders Place Their Bets

In other Sotera Health news, Director Gtcr Investment Xi Llc sold 12,735,301 shares of the business’s stock in a transaction that occurred on Wednesday, May 13th. The stock was sold at an average price of $15.17, for a total value of $193,194,516.17. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 15.36% of the company’s stock.

Sotera Health Stock Performance

NASDAQ SHC opened at $17.24 on Tuesday. The stock has a 50-day simple moving average of $16.69 and a two-hundred day simple moving average of $16.37. The firm has a market capitalization of $4.92 billion, a P/E ratio of 42.05 and a beta of 1.76. Sotera Health Company has a fifty-two week low of $11.00 and a fifty-two week high of $19.85. The company has a debt-to-equity ratio of 3.56, a quick ratio of 2.54 and a current ratio of 2.82.

Sotera Health (NASDAQ:SHC) last issued its earnings results on Tuesday, May 5th. The company reported $0.18 EPS for the quarter, topping analysts’ consensus estimates of $0.17 by $0.01. Sotera Health had a return on equity of 39.73% and a net margin of 9.91%.The firm had revenue of $280.05 million for the quarter, compared to the consensus estimate of $270.78 million. During the same quarter in the prior year, the business earned $0.14 earnings per share. The company’s revenue was up 10.0% compared to the same quarter last year. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. On average, equities analysts forecast that Sotera Health Company will post 0.87 earnings per share for the current year.

Sotera Health Profile

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.